NASA to test Pluristem's PLX cells for space mission-related indications

The NASA Ames Research Center will study the potential of placenta-based PLX cell therapies from Pluristem Therapeutics Inc. (NASDAQ:PSTI; Tel Aviv:PSTI) to prevent and treat medical conditions resulting from space missions in astronauts under a sponsored research agreement with the company.

The collaborative project, titled "Therapeutic Stromal Cells for Health in Space," received a 2019 NASA Ames Research Innovation Award...